Safety Study of SPARC1104

Completed · Phase 3

Conditions studied: Spasticity

In brief

Open-label, safety study of SPARC1104 in subjects with spasticity due to multiple sclerosis

Key facts

Study ID

NCT01797185

Run by

Sun Pharma Advanced Research Company Limited

People needed

375

Starts

2013-04-09

Expected to finish

2017-10-01

Last updated by the study team

2019-05-03

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

Where it is running

• SPARC Site 34 — Phoenix, Arizona, United States
• SPARC Site 1 — Tucson, Arizona, United States
• SPARC Site 30 — Costa Mesa, California, United States
• SPARC Site 14 — Newport Beach, California, United States
• SPARC Site 32 — Basalt, Colorado, United States
• SPARC Site 5 — Denver, Colorado, United States
• SPARC Site 7 — Derby, Connecticut, United States
• SPARC site 47 — Hartford, Connecticut, United States
• SPARC Site 8 — New London, Connecticut, United States
• SPARC Site 50 — Washington D.C., District of Columbia, United States
• SPARC Site 35 — Maitland, Florida, United States
• SPARC Site 59 — Miami, Florida, United States
• SPARC Site 6 — Ormond Beach, Florida, United States
• SPARC Site 11 — Port Charlotte, Florida, United States
• SPARC Site 13 — Sarasota, Florida, United States
• SPARC Site 25 — Sunrise, Florida, United States
• SPARC Site 55 — Tampa, Florida, United States
• SPARC Site 33 — Tampa, Florida, United States
• SPARC site 45 — Lenexa, Kansas, United States
• SPARC Site 24 — Overland Park, Kansas, United States
• SPARC Site 44 — Louisville, Kentucky, United States
• SPARC site 36 — Alexandria, Louisiana, United States
• SPARC Site 21 — Baton Rouge, Louisiana, United States
• SPARC Site 61 — New Orleans, Louisiana, United States
• SPARC site 4 — Gilbert, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.